Melanocyte Stimulating Hormone, gamma 1 (MSHg1)
Référence MBS658184-5x1mg
Conditionnement : 5x1mg
Marque : MyBiosource
Melanocyte Stimulating Hormone, Gamma 1 (Mshg1) Peptide – Synthetic Peptide, ~95%. Purified by HPLC. Purity
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS658184MBS658184 is a peptide targeting MC1R. Also known as Melanocyte Stimulating Hormone, gamma 1 (MSHg1). Host: Synthetic peptide. More details
Product Overview
Online Datasheet in PDFProduct Name
Melanocyte Stimulating Hormone, gamma 1 (MC1R), Peptide
Full Product Name
Melanocyte Stimulating Hormone, gamma 1 (MSHg1)
Product Gene Name
MC1R peptide
Host
Synthetic peptide
Form/Format
Supplied as a lyophilized powder.
Purity/Purification
Highly Purified
~95%. Purified by HPLC.
~95%. Purified by HPLC.
Preparation and Storage
Lyophilized powder may be stored at 4 degree C for short-term only. Stable for 12 months at -20 degree C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20 degree C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.
Molecular Weight
34,706 Da
Chromosome Location
Chromosome: 16; NC_000016.9 (89984287..89987385). Location: 16q24.3
OMIM
155555
Sequence (linear)
Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2
Product Categories/Family for MC1R peptide
Molecular Biology; MB-Peptides
Other Notes
Small volumes of MC1R peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for MC1R. It may not necessarily be applicable to this product.
NCBI Official Full Name
Melanocyte-stimulating hormone receptor
NCBI Official Synonym Full Names
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
NCBI Official Symbol
MC1R
NCBI Official Synonym Symbols
CMM5; MSH-R; SHEP2
UniProt Protein Name
Melanocyte-stimulating hormone receptor
UniProt Synonym Protein Names
Melanocortin receptor 1
Protein Family
Melanocyte-stimulating hormone receptor
UniProt Gene Name
MC1R
UniProt Synonym Gene Names
MSHR; MSH-R; MC1-R
UniProt Entry Name
MSHR_HUMAN
NCBI Protein Information
melanocyte-stimulating hormone receptor; MC1-R; melanotropin receptor
NCBI Summary for MC1R
This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for MC1R
Function: Receptor for MSH (alpha, beta and gamma) and ACTH. The activity of this receptor is mediated by G proteins which activate adenylate cyclase.
Subunit structure: Interacts with MGRN1, but does not undergo MGRN1-mediated ubiquitination; this interaction competes with GNAS-binding and thus inhibits agonist-induced cAMP production. Ref.14
Subcellular location: Cell membrane; Multi-pass membrane protein.
Tissue specificity: Melanocytes and corticoadrenal tissue.
Polymorphism: Genetic variants in MC1R define the skin/hair/eye pigmentation variation locus 2 (SHEP2) [
MIM:266300]. Hair, eye and skin pigmentation are among the most visible examples of human phenotypic variation, with a broad normal range that is subject to substantial geographic stratification. In the case of skin, individuals tend to have lighter pigmentation with increasing distance from the equator, with type I skin being the most lightly pigmented and type IV the most dark pigmented. By contrast, the majority of variation in human eye and hair color is found among individuals of European ancestry, with most other human populations fixed for brown eyes and black hair. Partial loss-of-function mutations are associated with fair skin, poor tanning and increased skin cancer risk.MC1R variants associated with red hair and fair skin, determine female-specific increased analgesia from kappa-opioid receptor agonist [
MIM:613098].
Involvement in disease: Melanoma, cutaneous malignant 5 (CMM5) [MIM:613099]: A malignant neoplasm of melanocytes, arising de novo or from a pre-existing benign nevus, which occurs most often in the skin but also may involve other sites.Note: Disease susceptibility is associated with variations affecting the gene represented in this entry. Ref.24 Ref.27
Sequence similarities: Belongs to the G-protein coupled receptor 1 family.
Show more Subunit structure: Interacts with MGRN1, but does not undergo MGRN1-mediated ubiquitination; this interaction competes with GNAS-binding and thus inhibits agonist-induced cAMP production. Ref.14
Subcellular location: Cell membrane; Multi-pass membrane protein.
Tissue specificity: Melanocytes and corticoadrenal tissue.
Polymorphism: Genetic variants in MC1R define the skin/hair/eye pigmentation variation locus 2 (SHEP2) [
MIM:266300]. Hair, eye and skin pigmentation are among the most visible examples of human phenotypic variation, with a broad normal range that is subject to substantial geographic stratification. In the case of skin, individuals tend to have lighter pigmentation with increasing distance from the equator, with type I skin being the most lightly pigmented and type IV the most dark pigmented. By contrast, the majority of variation in human eye and hair color is found among individuals of European ancestry, with most other human populations fixed for brown eyes and black hair. Partial loss-of-function mutations are associated with fair skin, poor tanning and increased skin cancer risk.MC1R variants associated with red hair and fair skin, determine female-specific increased analgesia from kappa-opioid receptor agonist [
MIM:613098].
Involvement in disease: Melanoma, cutaneous malignant 5 (CMM5) [MIM:613099]: A malignant neoplasm of melanocytes, arising de novo or from a pre-existing benign nevus, which occurs most often in the skin but also may involve other sites.Note: Disease susceptibility is associated with variations affecting the gene represented in this entry. Ref.24 Ref.27
Sequence similarities: Belongs to the G-protein coupled receptor 1 family.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Pathways associated with MC1R peptide
| Products by Pathway | Pathway Diagram |
|---|---|
| Chaperonin-mediated Protein Folding Pathway antibodies | Chaperonin-mediated Protein Folding Pathway Diagram |
| Class A/1 (Rhodopsin-like Receptors) Pathway antibodies | Class A/1 (Rhodopsin-like Receptors) Pathway Diagram |
| Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding Pathway antibodies | Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding Pathway Diagram |
| Formation Of Tubulin Folding Intermediates By CCT/TriC Pathway antibodies | Formation Of Tubulin Folding Intermediates By CCT/TriC Pathway Diagram |
| G Alpha (s) Signalling Events Pathway antibodies | G Alpha (s) Signalling Events Pathway Diagram |
| GPCR Downstream Signaling Pathway antibodies | GPCR Downstream Signaling Pathway Diagram |
| GPCR Ligand Binding Pathway antibodies | GPCR Ligand Binding Pathway Diagram |
| GPCRs, Class A Rhodopsin-like Pathway antibodies | GPCRs, Class A Rhodopsin-like Pathway Diagram |
| Melanogenesis Pathway antibodies | Melanogenesis Pathway Diagram |
| Melanogenesis Pathway antibodies | Melanogenesis Pathway Diagram |
Diseases associated with MC1R peptide
| Disease Name | Pubmed Publications |
|---|---|
| Melanoma Antibodies | >291 publications with MC1R and Melanoma |
| Neoplasms Antibodies | >247 publications with MC1R and Neoplasms |
| Skin Neoplasms Antibodies | >156 publications with MC1R and Skin Neoplasms |
| Neoplasms, Experimental Antibodies | >29 publications with MC1R and Neoplasms, Experimental |
| Inflammation Antibodies | >28 publications with MC1R and Inflammation |
| Carcinoma Antibodies | >26 publications with MC1R and Carcinoma |
| Carcinoma, Basal Cell Antibodies | >23 publications with MC1R and Carcinoma, Basal Cell |
| Necrosis Antibodies | >12 publications with MC1R and Necrosis |
| Vitiligo Antibodies | >7 publications with MC1R and Vitiligo |
| Congenital Abnormalities Antibodies | >6 publications with MC1R and Congenital Abnormalities |
Organs/Tissues associated with MC1R peptide
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Skin Antibodies | >406 publications with MC1R and Skin |
| Eye Antibodies | >54 publications with MC1R and Eye |
| Brain Antibodies | >41 publications with MC1R and Brain |
| Kidney Antibodies | >27 publications with MC1R and Kidney |
| Liver Antibodies | >16 publications with MC1R and Liver |
| Bone Antibodies | >13 publications with MC1R and Bone |
| Muscle Antibodies | >9 publications with MC1R and Muscle |
| Connective Tissue Antibodies | >6 publications with MC1R and Connective Tissue |
| Intestine Antibodies | >5 publications with MC1R and Intestine |
| Embryonic Tissue Antibodies | >5 publications with MC1R and Embryonic Tissue |


